Pharmacology & ToxicologybioRxivPreprint
A Dual-Action Mechanism to Prevent OX40 Signaling: The Structural Basis for the Differentiated Antagonist STAR-0310
Nikolaos Biris, Chunxia Zhao, Julie Macoin…·Christopher G. Bunick
This paper describes the structural basis of STAR-0310, a novel anti-OX40 antibody, which prevents OX40 signaling through a dual mechanism of blocking receptor trimerization and disrupting pre-formed complexes, showing greater efficiency than comparator antibodies.
DOI 10.1101/2025.09.16.676329